MetaCap

Cadrenal Therapeutics Statistics

NASDAQ: CVKDHealth CareBiotechnology: Pharmaceutical PreparationsUSD

1.70+0.01 (+0.59%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Cadrenal Therapeutics by the numbers

Cadrenal Therapeutics has a market capitalization of $7.0 million based on 4.12M shares outstanding. With trailing EPS of $-3.67, Cadrenal Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 49.6% above its 50-day average and 51.6% below its 200-day average.

Average daily trading volume is 496.14K shares, or about $843,447 in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

CVKD valuation vs. peer median

CVKD compared with the median of 8 peer companies
MetricCVKDPeer medianDifference
Market cap$7.01M$7.00M+0%
Avg. volume496.14K1.28M-61%

Peer median across 8 companies: TCRT, ENSC, CURX, MTVA, IMRN, BFRG, RKTO, VTGN.

Valuation

Price and trading

Previous close
1.69
Open
1.69
Day range
1.52 – 1.85
52-week range
0.816 – 12.50
Beta
—
Volume
206.57K

Dividends and events

Annual dividend
None
Next earnings date
Nov 23, 2026

Additional statistics

Market Cap
7.01M
Forward Pe
-0.50
Eps
-3.67
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
12.50
Week52 Low
0.82
Avg Volume
496.14K
Shares Outstanding
4.12M
Ma50
1.14
Ma200
3.51
Earnings Date
Nov 23, 2026
Pct From52w High
-86.40%
Pct From52w Low
108.33%

Related